Diagnostic and Biotech

2015-2019 Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market: Supplier Shares and Country Forecasts

  • VPG323038
  • 1200 Pages
  • August 2015
  • Diagnostic and Biotech
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100.

2015-2019 Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market is a new seven-countrystrategic analysis of the major business opportunities emerging in the cancer diagnostics market during the nextfive years. The report examines trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.



Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Worldwide Market Overview


- Estimated universe of laboratories performing cancer diagnostic testing

by country.


- Five-year test volume and sales projections by country.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Cancer Diagnostic TestsOver 200 current and emerging assays including:


ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,

Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,

Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,

Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,

Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,

Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,

Tissue Polypeptide Antigen, and others.


Geographic Coverage


France, Germany,
Italy, Japan,
Spain, UK, USA


Market Segmentation Analysis


- Sales and market shares of major suppliers,

by individual cancer diagnostic test and country.


- Five-year test volume and sales forecasts

for major cancer diagnostic tests

by country and market segment, including:


- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices

- Cancer Clinics

- Ambulatory Care Centers


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers

by country.


- Cancer statistics, etiology and recent developments in the

U.S., Japan and five major European countries.


Current and Emerging Products


- Review of over 200 current and emerging cancer diagnostic tests,

including:


- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.

- Instrumentation review analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operatingcharacteristics, features and selling prices.


Technology Assessment


- Assessment of monoclonal antibodies, immunoassays, DNA

probes, biochips/microarrays, chromosome analysis, IT,

artificial intelligence, flow cytometry, biosensors, and other technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies, including

CT, MRI, NMR, PET and photonics spectroscopy.


- Extensive listings of over 500 companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments ofmajor suppliers

and start-up firms developing innovative

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


Contains 1,200 pages and 450 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Protein Purification and Isolation Market - Opportunities and Forecasts, 2015 - 2020

Protein purification is the process of isolating proteins from the complex mixtures of cells, tissues, or organisms based on differences in their physical properties. The protein purification process aims to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Plasma Fractionation Market - Opportunities and Forecasts, 2015 - 2020

Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Exocrine Pancreatic Insufficiency Market (Mode of Disease management, Type of diagnostic tests and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global DNA Vaccines Market (Type, Technology, Application, End User and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Genotyping Market - Opportunities and Forecasts, 2015 - 2020

Genotyping is the process of studying DNA sequence to determine genetic constitution in the genotypes of living organisms, such as humans, plants, animals, and microorganisms. Human genotyping helps in determining ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global C-Reactive Protein Testing Market (Application, Types of Assays and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>